CAS: 7780-20-3; (E/z)-Piperine

化学文摘社编号7780-20-3与这一特定化合物有关,便于在化学数据库中识别;与许多有机化合物一样,其溶解性,熔点和其他物理特性取决于特定条件和功能组的存在;在处理和使用时,应参考安全数据,因为具有类似结构的化合物具有不同程度的毒性和再活性.

结构式图片

上下游产品

Acetic acid 1-(benzenesulfonyl-benzo[1,3]dioxol-5-yl-methyl)-4-oxo-4-piperidin-1-yl-butyl ester piperidine 5-(chloromethyl)-1,3-benzodioxole piperonolpiperic acid 1-((2E,4E)-5-(1,3-benzodioxol-5-yl)-2,4-pentadien-1-yl)-piperidine N-piperoylglycine N-(2-hydroxyethyl)-3-nitro-4-[2-(piperidin-1-ylcarbonyl)pyrrol-1-yl]benzamide

合成工艺路线路线简述

    胡椒碱 反应 2.5H,反应生成 胡椒碱
    参考文献:Vicinal Difluorination As A C=c Surrogate: An Analog Of Piperine With Enhanced Solubility,Photostability,And Acetylcholinesterase Inhibitory Activity
    标题:Vicinal Difluorination As A C=c Surrogate: An Analog Of Piperine With Enhanced Solubility,Photostability,And Acetylcholinesterase Inhibitory Activity
    摘要:胡椒碱是一种从花椒中提取的天然产物,具有多种生物活性,是一种极具吸引力的药物化学先导化合物.然而,胡椒碱的理化性质存在一些问题,包括水溶性差和容易受紫外线诱导降解.在这项研究中,我们设计了一种哌啶类似物,其中的中心共轭烃链被一个二氟烷基取代.我们的研究表明,这种含氟哌啶类似物具有更优越的理化性质,而且对一个特定的药物靶点--乙酰胆碱酯酶--具有更高的效力和选择性.这项工作凸显了三代二氟烷基作为 E-烯的替代物在药物化学中的潜在用途.
    DOI:10.3762/bjoc.16.216

    海关参考信息

    专利信息


    专利号:WO-2024181781-A1
    优先权日:2023-02-27
    标 题:Substrate for synthesis of biological polymers having anti-aggregation function and biological polymer synthesis method using same
    发明人:JANG MYOUNG HOON; CHOI JAE SUN
    权利人:SP2 TX INC
    摘要:The present invention relates to a substrate for the synthesis of biological polymers having an anti-aggregation function, and a biological polymer synthesis method using the substrate. The substrate according to an aspect may have anti-aggregation functionality to enable high-yield and high-purity processes in the synthesis of biological polymers.

    专利号:US-5962515-A
    优先权日:1997-05-29
    标题 :Process for isolation and synthesis of 1-(3,4 methylenedioxy-phenyl)-1E-tetradecene and its analogues and their activities against tumors and infections
    发明人:UPADHYAY SHAKTI N; VISHWAKARMA RAM A; GHOSAL SABARI; SHUKLA SUPRIYA; BOSE CHANDA; KAMRA ANITA
    权利人:NAT INST IMMUNOLOGY
    摘要:Process for isolation of 1-(3,4-methylenedioxy-phenyl)-1E-tetradecene from Piper longum. Processes for synthesis of 1-(3,4-methylenedioxy-phenyl)-1E-tetradecene; its stereoisomers and analogues are disclosed. The compounds isolated and synthesized according to this invention have immunomodulatory properties and can be used to treat tumors and infections.

    专利号:US-2021315830-A1
    优先权日:2018-08-31
    标题 :A curcumin loaded stabilized polymeric nanoparticles with increased solubility and photo-stability and a green process for the synthesis thereof
    发明人:ACHARYA AMITABHA; KUMARI AVNESH; GULIANI ANIKA; KUMAR SANJAY
    权利人:COUNCIL SCIENT IND RES
    摘要:The present invention explored PLGA NPs synthesis using plant extracts as surfactants by nanoprecipitation process. PLGA NPs synthesized using Camellia sinensis, Dendrocalamus hamiltonii, Ficus palmata and Rubus ellipticus leaf extracts were further explored for encapsulation, controlled and sustained release of well-known antioxidant molecule, curcumin. This plant extract based nanoprecipitation process for the synthesis of PLGA NPs can be further explored for encapsulation of many other antioxidant molecules of therapeutic importance.

    专利号:US-11634741-B2
    优先权日:2013-11-20
    标 题:Synthesis of L-nucleic acids by means of an enzyme
    发明人:PECH ANDREAS; JAROSCH FLORIAN; JAHNZ MICHAEL; KLUSSMANN SVEN; DAVID RALF
    权利人:APTARION BIOTECH AG
    摘要:The present invention is related to a method for adding one or more L-nucleotides to the 3′end of a first L-nucleic acid, wherein the method comprises the step of reacting the one or more L-nucleotides with the first L-nucleic acid in the presence of a protein comprising a mutant enzymatic activity exhibiting moiety, wherein the enzymatic activity is capable of adding one or more L-nucleotides to the 3′ end of the first L-nucleic acid, wherein the mutant enzymatic activity exhibiting moiety comprises an amino acid sequence, wherein the amino acids of the amino acid sequence are D-amino acids, wherein the mutant enzymatic activity exhibiting moiety is a variant of an enzymatic activity exhibiting moiety, wherein the enzymatic activity exhibiting moiety consists of an amino acid sequence according to SEQ ID NO: 15 and wherein the amino acids of the amino acid sequence according to SEQ ID NO: 15 are D-amino acids, wherein the amino acid sequence of the mutant enzymatic activity exhibiting moiety differs from the amino acid sequence of the enzymatic activity exhibiting moiety consisting of an amino acid sequence according to SEQ ID NO: 15 at least at one amino acid position, preferably at three amino acid positions, and/or wherein the amino acid sequence of the mutant enzymatic activity exhibiting moiety is a truncated form of an amino acid sequence according to SEQ ID NO: 15, and wherein the amino acid sequence of the mutant enzymatic activity exhibiting moiety is different from an amino acid sequence according to any of SEQ ID NOs 15 to 22 and 51.

    专利号:US-9850471-B2
    优先权日:2012-05-16
    标题:Enzymatic synthesis of L-nucleic acids
    发明人:PECH ANDREAS; DAVID RALF; JAROSCH FLORIAN; JAHNZ MICHAEL; KLUSSMANN SVEN
    权利人:NOXXON PHARMA AG
    摘要:The invention relates to a method of reacting one or more L-nucleotides with a first L-nucleic acid in the presence of a D-enzyme that adds the one or more L-nucleotides to the 3′ end of the first L-nucleic acid.

    专利号:US-2019276389-A1
    优先权日:2015-12-18
    标题:Synthesis of aryl cyclohexane ester derivatives useful as sensates in consumer products
    发明人:WOS JOHN AUGUST; YELM KENNETH EDWARD; BUNKE GREGORY MARK; FREDERICK HEATH ALAN; REILLY MICHAEL; HAUGHT JOHN CHRISTIAN; SREEKRISHNA KOTI TATACHAR; LIN YAKANG
    权利人:PROCTER & GAMBLE
    摘要:Personal care compositions, such as oral care and skin care compositions containing a flavor/perfume system comprising one or more coolants. The pleasant cool sensation provided by a coolant is enhanced in terms of quicker onset, greater intensity, impact or longer duration, which improves appeal and acceptability of the compositions to consumers.
    河南倍特生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bisbio.com
    电话: 0371-67770926 13949121029👤
    📞河南倍特生物科技有限公司 ⚠️参考联系方式

    销售电话:0371-67770926 13949121029
    邮箱:sales@bisbio.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    西安绿天生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.plamed-extract.com
    电话: 400-992-1768👤
    📞西安绿天生物技术有限公司 ⚠️参考联系方式

    销售电话:400-992-1768
    邮箱:sales@plamed.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    西安天本生物工程有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.tianbensw.com
    电话: 029-88341709 88341708👤
    📞西安天本生物工程有限公司 ⚠️参考联系方式

    销售电话:029-88341709 88341708
    邮箱:foamy1983@live.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/s0968-0896(02)00130-x
    摘要:Tsukamoto S, Tomise K, Miyakawa K, Cha B, Abe T, Hamada T, Hirota H, Ohta T. CYP3A4 Inhibitory Activity of New Bisalkaloids, Dipiperamides D and E, and Cognates from White Pepper. Bioorganic & Medicinal Chemistry. 2002 Sep;10(9):2981–5. doi: 10.1016/s0968-0896(02)00130-x.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知